Sifrol® ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	6

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02248181 (ClinicalTrials.gov)	February 2004	22/9/2014	Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease	Post Marketing Surveillance Study of Sifrol® - Monotherapy in Patients With Idiopathic Parkinson's Disease	Parkinson Disease	Drug: Pramipexole	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	442	N/A	NULL
2	NCT02231905 (ClinicalTrials.gov)	January 2004	3/9/2014	Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease	Open Label, Exploratory Clinical Trial to Assess the Safety, Tolerability and Effectiveness of a Switching From Talipexole to Pramipexole	Parkinson Disease	Drug: BI-Sifrol®	Boehringer Ingelheim	NULL	Completed	20 Years	N/A	Both	29	Phase 4	NULL
3	NCT02248207 (ClinicalTrials.gov)	January 2003	22/9/2014	Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease	Management of Parkinson's Disease Patients at Their First Visits in a Neurological Practice	Parkinson Disease	Drug: Pramipexole	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	1293	N/A	NULL
4	NCT02231255 (ClinicalTrials.gov)	February 2002	2/9/2014	Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease	Switch Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease	Parkinson Disease	Drug: Sifrol®	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	1216	N/A	NULL
5	NCT02231294 (ClinicalTrials.gov)	July 2000	2/9/2014	The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease	The Effect of SIFROL® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease Patients.	Parkinson Disease	Drug: Sifrol®	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	1464	N/A	NULL
6	NCT02248220 (ClinicalTrials.gov)	October 1998	22/9/2014	Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease	Observation of the Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease	Parkinson Disease	Drug: Pramipexole	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	657	N/A	NULL

Back to top